199 related articles for article (PubMed ID: 37658132)
1. Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis.
Huang Y; Yang W; Yang L; Wang T; Li C; Yu J; Zhang P; Yin Y; Li R; Tao K
Sci Rep; 2023 Sep; 13(1):14359. PubMed ID: 37658132
[TBL] [Abstract][Full Text] [Related]
2. In vitro siRNA-mediated GPX4 and AKT1 silencing in oxaliplatin resistance cancer cells induces ferroptosis and apoptosis.
Golbashirzadeh M; Heidari HR; Aghamolayi AA; Fattahi Y; Talebi M; Khosroushahi AY
Med Oncol; 2023 Aug; 40(10):279. PubMed ID: 37632628
[TBL] [Abstract][Full Text] [Related]
3. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin.
Yang C; Zhang Y; Lin S; Liu Y; Li W
Aging (Albany NY); 2021 Mar; 13(10):13515-13534. PubMed ID: 33819186
[TBL] [Abstract][Full Text] [Related]
4. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rh3 induces pyroptosis and ferroptosis through the Stat3/p53/NRF2 axis in colorectal cancer cells.
Wu Y; Pi D; Zhou S; Yi Z; Dong Y; Wang W; Ye H; Chen Y; Zuo Q; Ouyang M
Acta Biochim Biophys Sin (Shanghai); 2023 Apr; 55(4):587-600. PubMed ID: 37092860
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin induces ferroptosis and oxidative stress in HT29 colorectal cancer cells by inhibiting the Nrf2 signaling pathway.
Liu B; Wang H
Exp Ther Med; 2022 Jun; 23(6):394. PubMed ID: 35495610
[TBL] [Abstract][Full Text] [Related]
7. Targeting critical pathways in ferroptosis and enhancing antitumor therapy of Platinum drugs for colorectal cancer.
Wang G; Wang JJ; Zhi-Min Z; Xu XN; Shi F; Fu XL
Sci Prog; 2023; 106(1):368504221147173. PubMed ID: 36718538
[TBL] [Abstract][Full Text] [Related]
8. FOXA2 Suppression by TRIM36 Exerts Anti-Tumor Role in Colorectal Cancer Via Inducing NRF2/GPX4-Regulated Ferroptosis.
Liu X; Yan C; Chang C; Meng F; Shen W; Wang S; Zhang Y
Adv Sci (Weinh); 2023 Dec; 10(35):e2304521. PubMed ID: 37875418
[TBL] [Abstract][Full Text] [Related]
9. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
[TBL] [Abstract][Full Text] [Related]
10. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
Wang Z; Sun X; Feng Y; Wang Y; Zhang L; Wang Y; Fang Z; Azami NLB; Sun M; Li Q
Phytomedicine; 2021 Feb; 82():153414. PubMed ID: 33461143
[TBL] [Abstract][Full Text] [Related]
11. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer.
Yang W; Wang Y; Huang Y; Yu J; Wang T; Li C; Yang L; Zhang P; Shi L; Yin Y; Tao K; Li R
Biomed Pharmacother; 2023 Mar; 159():114301. PubMed ID: 36706634
[TBL] [Abstract][Full Text] [Related]
12. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells.
Wei R; Zhao Y; Wang J; Yang X; Li S; Wang Y; Yang X; Fei J; Hao X; Zhao Y; Gui L; Ding X
Int J Biol Sci; 2021; 17(11):2703-2717. PubMed ID: 34345202
[No Abstract] [Full Text] [Related]
13. Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer.
Wu W; Zhao Y; Qin B; Jiang X; Wang C; Hu R; Ma R; Lee MH; Liu H; Li K; Yuan P
EBioMedicine; 2023 Jul; 93():104650. PubMed ID: 37343364
[TBL] [Abstract][Full Text] [Related]
14. Lysionotin Induces Ferroptosis to Suppress Development of Colorectal Cancer via Promoting Nrf2 Degradation.
Gao Z; Jiang J; Hou L; Ji F
Oxid Med Cell Longev; 2022; 2022():1366957. PubMed ID: 35993016
[TBL] [Abstract][Full Text] [Related]
15. Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1 signalling pathway in KRAS mutant colorectal cancer.
Yang J; Mo J; Dai J; Ye C; Cen W; Zheng X; Jiang L; Ye L
Cell Death Dis; 2021 Nov; 12(11):1079. PubMed ID: 34775496
[TBL] [Abstract][Full Text] [Related]
16. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis.
Lin JF; Hu PS; Wang YY; Tan YT; Yu K; Liao K; Wu QN; Li T; Meng Q; Lin JZ; Liu ZX; Pu HY; Ju HQ; Xu RH; Qiu MZ
Signal Transduct Target Ther; 2022 Feb; 7(1):54. PubMed ID: 35221331
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the Nrf2 Promoter Induces Ferroptosis by Inhibiting the Nrf2-GPX4 Axis in COPD.
Zhang Z; Fu C; Liu J; Sai X; Qin C; Di T; Yang Y; Wu Y; Bian T
Int J Chron Obstruct Pulmon Dis; 2021; 16():3347-3362. PubMed ID: 34934311
[TBL] [Abstract][Full Text] [Related]
20. Activation of Nrf2 inhibits ferroptosis and protects against oxaliplatin-induced ototoxicity.
Xu K; Chang X; Bai X; Liu HB; Chen XB; Chen HP; Liu YH
Biomed Pharmacother; 2023 Sep; 165():115248. PubMed ID: 37523980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
